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observed in 6 and 8 measurements (total of 26.9%), respectively, but 
only 2 measurement were over 10%. Four of the six measurements on 
the anal verge showed difference of 5% or more between the 
calculated and estimated dose.  
Conclusions: With high dose gradients in VMAT treatments it is 
essential to know the correct position of TLDs in order to properly 
analyze the results of in-vivo dosimetry. This new procedure seems 
dealing with this issue, allowing validating and monitoring doses 
delivered to patients.  
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Purpose/Objective: The clinical importance of the discrepancies 
detected in pre-treatment IMRT QA is often difficult to interpret. This 
seems to be possible by using a recent commercial software, 3DVH 
(SunNuclear, USA), that relies on field QA data to reconstruct a 3D 
dose distribution in the patient. A study is planned in our Institute to 
compare IMRT calculated dose distributions to the delivered ones 
reconstructed from QA results. In this work, we present the feasibility 
study dealing with the validation of the used software and methods.  
Materials and Methods: The validation study introduced deliberate 
errors in a sample of clinical plans to simulate delivery/calculation 
errors (modified plan). Then the error-free beams were used to 
generate virtual planar QA measures and input to SNC Patient 
software, which generates a PDP (Planned Dose Perturbation) file 
containing information about QA and calculated doses. The DICOM RT 
files together with the PDP file were loaded into the 3DVH software to 
reconstruct the error-free 3D patient doses by perturbing the modified 
plan. MU delivery errors of ±4% were simulated in the TPS. MLC errors 
were simulated by opening and closing leaves of one MLC bank by 1 
mm or 2 mm. The comparison between the 3DVH reconstructed dose 
and the original unmodified plan is performed in terms of the main 
DVH parameters of PTVs and OARs. Finally, the 3DVH software was 
applied to a sample of 10 head-and-neck (H&N, highly modulated due 
to simultaneous delivery of different doses to 3 PTVs) clinical plans 
and relative pre-tx QA performed with a diode array (Mapcheck2, 
SunNuclear, USA). The 3D γ-matching rates of the reconstructed plans 
are compared with the γ-passing rate of per-beam planar measures to 
detect possible correlations. 
Results: Fig. 1 shows the impact on the main DVH parameters of the 
simulated errors, as given by the 3DVH software. As expected, dose 
(MU) errors have a larger impact on PTVs than changes in MLC 
positions. In particular, a ± 4% change in MU is associated to a change 
in the PTVs mean dose of + 4.16 ± 0.01% and -3.84 ± 0.01%, 
respectively, suggesting a slight bias of 0.2%. Similar results have been 
obtained for OARs’ mean dose, while the impact of MLC error results 
more important than MU change. As for the capability of the 3DVH 
software to accurately reconstruct the original plan from the modified 
plan by using the virtual planar measures, all results give an almost 
perfect match of the 2 plans. Small differences are found only for 
very small volumes such as parotids. Finally, the application of 3DVH 
to our 10 H&N clinical sample has shown no significant correlation 
between the γ passing rates of single beam QA and the 3D matching 
rate of the reconstructed plan; better correlation is found with the 
minimum value of γ passing rates obtained in QA per-beam measures. 
 
  
Conclusions: Validation of 3DVH software against TPS has shown good 
results. Application to clinical plans using real QA data shows that the 
dosimetric discrepancies detected in individual field QA are not 
correlated to the γ of the reconstructed plan.  
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Purpose/Objective: The purpose of the study is to clinically validate 
the Gated dose delivery for mobile targets with VMAT using Electronic 
Portal Imaging Device (EPID). 
Materials and Methods: The advantage of Gated RapidArc (G-RA) 
technology is that it reduce the margin of Internal Target volume (ITV) 
which reduces the dose to OAR's adjacent to the mobile tumours. G-
RA was delivered using the Varian Real-Time Position Management 
(RPM) system which uses external retro reflective infrared markers to 
generate gate-open signals of different durations. To assure the 
proper dynamic dose delivery and MLC position of G-RA treatments, 
we selected five lung cases and RA plans were created in Varian 
Eclipse(v10) Treatment Planning System (TPS). Verification plans were 
generated using portal dosimetry and Portal Dose Prediction Algorithm 
(PDIP v10) is used to predict the portal dose at the isocenter. All plans 
were executed in Clinac-iX treatment machine and portal dose images 
were acquired using EPID, while Infrared reflecting box is periodically 
moved to provide gating signal for RPM system.To evaluate the 
accuracy of dose delivery, measurements were performed for 
different duty cycles (80%, 50% & 20%) and were compared with the 
portal doses of non-gated RA of the same plan. Earlier the non-Gated 
RA plans were compared with the TPS predicted portal dose. Area 
gamma and dose difference was analyzed in portal dosimetry 
workspace in Eclipse for the criteria 2mm Distance to Agreement 
(DTA) & 2% Dose Difference (DD) and 3mm & 3%.MLC Dynalog files 
were analyzed and expressed as root mean square (RMS) of the 
deviations of individual leaves during treatment delivery. 
Results: The accuracy of gated RapidArc dose delivery is compared 
against the non gated RapidArc delivery using electronic portal 
imaging device. The average area gamma less than 1 for duty cycles 
80%, 50%,& 20% were 99.84(±0.19), 99.5(±0.29), 87.52(±1.57) for 2mm 
DTA & 2% DD and 100.0(±0.0), 99.98(±0.05), 98.96(±0.87) for 3mm 
DTA & 3% DD respectively. Average of maximum error root mean 
square for all MLC positions were 0.074mm (±0.0059), 




Conclusions: Gated RapidArc delivery validated using EPID and results 
exhibits that there is good agreement between delivery of G-RA and 
non gated RapidArc. For fast, accurate and its highspatial resolution, 
EPID can be used as a verification tool for gated RA delivery. 
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Purpose/Objective: Radiochromic films are recognized to be suitable 
for patient specific QA in IMRT treatments verification because of high 
spatial resolution, near-tissue equivalence and weak energy 
dependence. Challenges in radiochromic films dosimetry using a 
multichannel flatbed scanner, are related to uncertainties due mainly 
to scanner non-uniformity and film thickness difference within films 
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area. Different analysis techniques have been proposed to increase 
the accuracy of radiochromic films dose distribution measurements.  
The aim of this work is to compare the results obtained whit different 
analysis techniques in assessing dose distribution for IMRT photon 
beams pre-treatment verification.  
Materials and Methods: Gafchromic®EBT3 films have been calibrated 
irradiating 5x5 cm film pieces with a 6 MV linac photon beam at 
different dose levels in a range from 10 to 400 cGy at 5cm depth in 
PMMA phantom and SSD 95 cm. Then 40 IMRT clinical beams have been 
verified by gafchromic films with the same irradiation setup. Films 
have been scanned with a Epson 10000XL flatbed scanner 24 hours 
after irradiation and dose distributions have been assessed using an 
home-made software. Our software allows to perform analysis in 4 
different ways: red channel (R) analysis, red channel analysis with the 
correction for the scanner non-uniformities (RC), the red/blue 
channels (RB) analysis and the 3 channel (RGB) analysis using formulas 
proposed by Mayer (Med. Phys. 2012). The films absolute dose 
distributions obtained have been compared with the calculated ones 
by means of 3%(local)/3mm gamma analysis.  
Results: Gamma analysis pass rates obtained with RGB analysis 
(98.0±2.7) are higher than pass rates obtained with all the other 
analysis approaches, while the lowest mean pass rate (88.9±13.3) has 
been obtained, as is was expected, evaluating the dose distribution 
using the R analysis. Comparing RB and RC techniques, the last one 
provide better results (96.5 ± 3.4 vs 94.1 ± 7.2). Moreover standard 
deviations of mean values are inversely proportional to gamma pass 
rates meaning that methods giving higher pass rates are also more 
consistent. 
Conclusions: The newly proposed three channels analysis allows to 
take in account different source of inaccuracy increasing the 
gafchromic films capability to measure IMRT dose distributions.  
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Purpose/Objective: Verification of the position of MLC leaves is an 
essential part of routine linac quality assurance. This is particularly 
true when more advanced treatment techniques such as 
VMAT/RapidArc and IMRT are used. These treatments are typically 
built up out of smaller, possibly abutting fields, amplifying the effect 
of any mispositioning of the leaves. The Elekta Agility MLC (Elekta, 
Crawley, UK) has 160 leaves, with 0.5 cm effective leaf width in the 
isocentre. It comes with an automated tool to calibrate the leaf 
position offsets and motion gains. This is a 'black-box', and direct 
control over leaf positioning is no longer possible, but independent 
verification is still essential. The aim of the research presented was 
twofold: 1. To test the MLCSoftEPID software (PTW, Freiburg, 
Germany) as a quick tool for routine MLC QA, as an alternative to 
detector arrays or film. 2. To test the positioning stability of the 
Elekta Agility MLC. 
Materials and Methods: An Elekta Synergy linac fitted with an Agility 
MLC was used. The EPID used was an IviewGT amorphous silicon 
1024x1024 pixel EPID, with a 41x41 cm detection area (Perkin-Elmer, 
Waltham Massachusetts, US). MLCSoftEPID software was used for 
analysis. This software package requires a standard set of EPID images 
to be acquired for accurate alignment of the coordinate system of the 
EPID panel in relation to the linac collimator, followed by a series of 
strip images from which the leaf positions are then determined, 
analogous to a picket-fence test. Measurements were compared to our 
institute's standard SLA-48 (PTW, Freiburg, Germany), a linear array of 
ionization chambers mounted on a stepper motor. To test whether the 
measurement of a leaf's position is influenced by the position of 
neighbouring leaves, images were also made with all odd-numbered 
leaves intentionally offset by 2 mm compared to even-numbered 
leaves. In this case, the 50% dose level is no longer directly beneath 
what would normally be considered the leaf position, due to the 
nonzero size of the point spread function (see figure). Positioning 
accuracy for each leaf was tracked biweekly over a period of multiple 
months. 
  
Results: A routine leaf position QA check using MLCSoftEPID can be 
done within 10 minutes. Consecutive leaf position measurements using 
the EPID were found to be reproducible within 0.1mm every time, 
comparable to or better than traditional alternatives, and agree with 
conventional SLA-48 measurements within 0.3 mm. Over the 3 months 
during which leaf stability was measured, all individual leaf positions 
of the Agility deviated by less than 0.2mm. A non-negligible effect 
caused by a mispositioning of neighbouring leaves on the position of a 
leaf as measured by EPID was found. The size of this effect is on the 
order of 25% of the neighbouring leaf's offset. 
Conclusions: The leaf positioning stability of the Elekta Agility is 
within 0.2mm, over a 3 month period half a year after installation. 
The MLCSoftEPID software is a useful alternative to current methods 
of leaf positioning QA used in our institute.  
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Purpose/Objective: Due to the complexity of volumetric modulated 
arc therapy (VMAT), new verification techniques are required. Some 
new systems allow calculation of DVHs from the measured dose 
distribution. In this feasibility study we compare this feature in the 
commercially available 3DVH option of ArcCheck (SunNuclear) with 
the EPID based 3D dosimetry approach that was developed by the NKI-
AVL in Amsterdam and that is being tested in our hospital. 
Materials and Methods: For two different clinical VMAT cases 
(prostate & oesophagus) planned with MONACO (Elekta) we measured 
the clinical treatment plans on a cylindrical phantom with ArcCheck 
and a rectangular phantom with EPID dosimetry at a Synergy (Elekta) 
linac. ArcCheck translates deviations measured by the diodes at the 
outer boundary of the phantom to deviations in the delivered patient 
dose.The EPID dosimetry uses a back projection algorithm to convert 
doses measured at the EPID to 3D doses inside the patient or 
phantom. To study the sensitivity of both methods, two types of 
delivery errors have been introduced in the delivered treatment 
plans. Systematic errors in the leaf position calibration of 0.5, 1, 1.5, 
and 2mm (open or close) and fixing leaf positions during treatment (of 
1 or 2 leaves). We have compared the gamma-statistics (3%/3mm) and 
the measured and planned DVHs. 
